Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
22-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #27150
advertisement
Hitzl W
14
Showing records 1 to 14 |
Display all abstracts from
Hitzl W
95253
Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Lenzhofer M
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 2351-2361
95520
TRPV4 mediates cell damage induced by hyperphysiological compression and regulates COX2/PGE2 in intervertebral discs
Cambria E; Heusser S
JOR spine
2021; 4: e1149
95253
Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Hohensinn M
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 2351-2361
95520
TRPV4 mediates cell damage induced by hyperphysiological compression and regulates COX2/PGE2 in intervertebral discs
Scheuren AC
JOR spine
2021; 4: e1149
95253
Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Hitzl W; Steiner V
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 2351-2361
95520
TRPV4 mediates cell damage induced by hyperphysiological compression and regulates COX2/PGE2 in intervertebral discs
Tam WK; Karol AA
JOR spine
2021; 4: e1149
95253
Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Motaabbed A
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 2351-2361
95520
TRPV4 mediates cell damage induced by hyperphysiological compression and regulates COX2/PGE2 in intervertebral discs
Hitzl W
JOR spine
2021; 4: e1149
95253
Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Motloch K; Colvin HP
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 2351-2361
95520
TRPV4 mediates cell damage induced by hyperphysiological compression and regulates COX2/PGE2 in intervertebral discs
Leung VY
JOR spine
2021; 4: e1149
95253
Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Reitsamer HA
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 2351-2361
95520
TRPV4 mediates cell damage induced by hyperphysiological compression and regulates COX2/PGE2 in intervertebral discs
Müller R; Ferguson SJ
JOR spine
2021; 4: e1149
95253
Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Moussa S
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 2351-2361
95520
TRPV4 mediates cell damage induced by hyperphysiological compression and regulates COX2/PGE2 in intervertebral discs
Wuertz-Kozak K
JOR spine
2021; 4: e1149
Issue
22-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept